• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    53 Stocks Moving In Thursday's Mid-Day Session

    6/2/22 12:17:59 PM ET
    $ACOR
    $AGLE
    $AHI
    $AI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ACOR alert in real time by email

    Gainers

    • Repare Therapeutics Inc. (NASDAQ:RPTX) jumped 38.1% to $12.08 after the company announced it has entered into a worldwide license and collaboration agreement with Roche for the development and commercialization of camonsertib. Repare will receive a $125 million upfront payment and is eligible to receive up to an additional $1.2 billion in potential milestones.
    • Redbox Entertainment Inc. (NASDAQ:RDBX) rose 28.1% to $7.18 after declining over 16% on Wednesday.
    • Yumanity Therapeutics, Inc. (NASDAQ:YMTX) gained 25.3% to $1.4288. Yumanity Therapeutics, last month, posted a Q1 loss of $1.24 per share.
    • Avaya Holdings Corp. (NYSE:AVYA) jumped 24.4% to $5.30.
    • MDJM Ltd (NASDAQ:MDJH) gained 24.2% to $2.0494.
    • Immix Biopharma, Inc. (NASDAQ:IMMX) rose 24.1% to $2.2950 after declining around 14% on Wednesday. Immix Biopharma, last month, announced positive interim data from an animal study in Soft Tissue Sarcoma (STS).
    • American Superconductor Corporation (NASDAQ:AMSC) gained 23.8% to $6.54 following Q4 results.
    • Missfresh Limited (NASDAQ:MF) rose 21.6% to $0.2978 after gaining over 51% on Wednesday.
    • electroCore, Inc. (NASDAQ:ECOR) gained 20.4% to $0.6204.
    • Credo Technology Group Holding Ltd (NASDAQ:CRDO) gained 20% to $12.30 after the company reported Q4 EPS results up from last year and better-than-expected sales results. The company also issued Q1 sales guidance above analyst estimates.
    • PyroGenesis Canada Inc. (NASDAQ:PYR) jumped 18.8% to $3.04. PyroGenesis announced project to introduce plasma torches into the upstream anode baking process.
    • Pure Storage, Inc. (NYSE:PSTG) shares climbed 18.6% to $28.48 after the company reported better-than-expected Q1 financials results. The company also issued Q2 and FY23 sales guidance above analyst estimates.
    • Chewy, Inc. (NYSE:CHWY) rose 18.5% to $27.85 after the company reported better-than-expected Q1 sales results.
    • Uranium Energy Corp. (NYSE:UEC) gained 17.6% to $4.1750.
    • MongoDB, Inc. (NASDAQ:MDB) rose 17.4% to $284.11 after the company reported Q1 EPS results up from last year and better-than-expected sales results. The company also issued Q2 sales guidance above analysts’ estimates.
    • Rain Therapeutics Inc. (NASDAQ:RAIN) jumped 17.2% to $2.86. Roth Capital initiated coverage on Rain Therapeutics with a Buy rating and announced a price target of $16.
    • Dunxin Financial Holdings Limited (NYSE:DXF) rose 17.2% to $0.58.
    • RISE Education Cayman Ltd (NASDAQ:REDU) gained 17.1% to $1.64.
    • Integrated Media Technology Limited (NASDAQ:IMTE) jumped 17% to $9.39.
    • UiPath Inc. (NYSE:PATH) shares rose 16.1% to $19.54 after the company reported better-than-expected Q1 EPS and sales results. The company also issued Q3 and FY23 sales guidance above analysts’ estimates.
    • Gevo, Inc. (NASDAQ:GEVO) gained 15.8% to $4.7401. Gevo, last month, reported better-than-expected Q1 sales results.
    • MicroVision, Inc. (NASDAQ:MVIS) jumped 15.6% to $3.9650.
    • Elastic N.V. (NYSE:ESTC) rose 15.4% to $71.50 after the company reported better-than-expected Q4 EPS and sales results.
    • KE Holdings Inc. (NYSE:BEKE) gained 15.1% to $14.58. KE Holdings recently announced better-than-expected Q1 sales results.
    • Onconova Therapeutics, Inc. (NASDAQ:ONTX) surged 14.9% to $1.3101.
    • Lands' End, Inc. (NASDAQ:LE) jumped 14.7% to $12.78 after the company reported better-than-expected Q1 EPS results.
    • Pineapple Energy Inc. (NASDAQ:PEGY) jumped 14.4% to $2.39.
    • Veeva Systems Inc. (NYSE:VEEV) surged 14% to $191.36 after the company reported better-than-expected Q1 EPS and sales results. The company also issued Q2 and FY22 EPS guidance above analysts estimates.
    • comScore, Inc. (NASDAQ:SCOR) gained 13.9% to $2.21. comScore Director Paul William Livek acquired a total of 600,000 shares at an average price of $1.92.
    • Bright Green Corporation (NASDAQ:BGXX) gained 13.3% to $4.0101 after dropping 30% on Wednesday.
    • Blue Apron Holdings, Inc. (NYSE:APRN) rose 9.7% to $3.3663 after the company announced it will be offering a selection of meal kits without a subscription on Walmart.com.


    Losers

    • Zosano Pharma Corporation (NASDAQ:ZSAN) fell 47.4% to $0.9250 after the company announced it filed a voluntary petition for relief under chapter 11.
    • Immunic, Inc. (NASDAQ:IMUX) shares dipped 41.2% to $3.47 after the company reported data from its Phase 2 CALDOSE-1 trial of Vidofludimus Calcium did not achieve the primary endpoint.
    • Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE) dropped 40.1% to $0.8983. Aeglea BioTherapeutics announced the U.S. Food and Drug Administration (FDA) has refused to accept the company’s Biologics License Application (BLA) with a Refusal to File (RTF) letter.
    • Centessa Pharmaceuticals plc (NASDAQ:CNTA) fell 20% to $3.60 after the company announced it has made a strategic decision to discontinue development of lixivaptan for Autosomal Dominant Polycystic Kidney Disease including both the Phase 3 ACTION study and the open-label ALERT study.
    • WiSA Technologies, Inc. (NASDAQ:WISA) declined 19.4% to $0.6456.
    • CASI Pharmaceuticals, Inc. (NASDAQ:CASI) fell 17% to $3.3740 following effect of 1:10 reverse stock split.
    • CN Energy Group. Inc. (NASDAQ:CNEY) dropped 15.6% to $1.73.
    • Innovid Corp. (NYSE:CTV) fell 15.4% to $2.9950.
    • Concert Pharmaceuticals, Inc. (NASDAQ:CNCE) shares declined 14.9% to $4.56 after the company priced its common stock offering of 10 million shares at $4.75 per share.
    • Midatech Pharma plc (NASDAQ:MTP) dropped 14.7% to $0.64. The U.S. Food and Drug Administration (FDA) recently granted Fast Track Designation to Midatech Pharma PLC's (NASDAQ:MTP) lead drug candidate MTX110 for the treatment of patients with recurrent glioblastoma (rGBM).
    • Acorda Therapeutics, Inc. (NASDAQ:ACOR) fell 14.6% to $0.38.
    • Limelight Networks, Inc. (NASDAQ:LLNW) declined 13.9% to $2.9950.
    • Energy Focus, Inc. (NASDAQ:EFOI) fell 13.5% to $1.0550 after jumping 37% on Wednesday.
    • Lightwave Logic, Inc. (NASDAQ:LWLG) dropped 12.4% to $6.95.
    • Mullen Automotive, Inc. (NASDAQ:MULN) fell 11.5% to $1.2550. Mullen Automotive recently announced results of its solid-state polymer battery testing with the Battery Innovation Center in Indiana.
    • Advanced Human Imaging Limited (NASDAQ:AHI) dropped 11.1% to $0.7225.
    • Histogen Inc. (NASDAQ:HSTO) shares fell 10.7% to $0.14. Histogen reported a 1-for-20 reverse stock split.
    • Nutex Health, Inc. (NASDAQ:NUTX) fell 10.5% to $9.64.
    • Enjoy Technology, Inc. (NASDAQ:ENJY) dropped 10.2% to $0.2563.
    • C3.ai, Inc. (NYSE:AI) shares fell 9.8% to $16.73 after the company issued Q1 and FY23 sales guidance below analyst estimates.
    • Conn's, Inc. (NASDAQ:CONN) dropped 9.2% to $11.38. The company reported mixed results for its first quarter.
    • Hewlett Packard Enterprise Company (NYSE:HPE) fell 6.6% to $14.75 after the company reported worse-than-expected Q2 financials results. The company also issued Q3 and FY22 EPS guidance with midpoints below analyst estimates.
    Get the next $ACOR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACOR
    $AGLE
    $AHI
    $AI

    CompanyDatePrice TargetRatingAnalyst
    Immix Biopharma Inc.
    $IMMX
    2/9/2026$14.00Outperform
    Mizuho
    KE Holdings Inc
    $BEKE
    2/3/2026$19.00Buy → Neutral
    Goldman
    Credo Technology Group Holding Ltd
    $CRDO
    1/21/2026$170.00Neutral
    Rosenblatt
    Veeva Systems Inc.
    $VEEV
    1/13/2026$215.00Sell
    Goldman
    Hewlett Packard Enterprise Company
    $HPE
    1/13/2026$31.00Buy
    Goldman
    Veeva Systems Inc.
    $VEEV
    1/8/2026Hold → Buy
    Truist
    MongoDB Inc.
    $MDB
    1/6/2026$480.00 → $500.00Buy
    Needham
    MongoDB Inc.
    $MDB
    12/16/2025Mkt Perform
    Raymond James
    More analyst ratings

    $ACOR
    $AGLE
    $AHI
    $AI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Anfield Energy Announces Special Shareholder Meeting and Mailing of Related Documents

    VANCOUVER, British Columbia, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Anfield Energy Inc. (TSX.V: AEC, NASDAQ:AEC, FRANKFURT: 0AD) ("Anfield" or the "Company") announces that today is the legal mailing date for the mailing and filing of the notice of a meeting of shareholders, the management information circular, and related documents (collectively, the "Meeting Materials") to convene a special meeting (the "Meeting") of shareholders. The Meeting will take place on February 27, 2026 at 10:00 AM (Vancouver Time). Copies of the Meeting Materials are available for review under the profile for the Company on SEDAR+ (www.sedarplus.ca) and on Anfield's corporate website (https://anfieldenergy.com). Th

    2/6/26 4:30:00 PM ET
    $AEC
    $UEC
    Metal Mining
    Basic Materials
    Other Metals and Minerals

    UiPath Acquires WorkFusion, Strengthening Agentic Solutions for Financial Services

    UiPath (NYSE:PATH), a global leader in agentic automation, today announced the acquisition of WorkFusion, a pioneer in AI agents for financial crime compliance. The acquisition expands and strengthens the UiPath portfolio of agentic AI-powered industry solutions for the financial services and banking industries, including processes and workflows for financial crimes compliance such as anti-money laundering (AML) and know your customer (KYC) operations. WorkFusion's pre-built library of AI agents automates the most labor-intensive aspects of financial crime compliance, from customer screening to investigations. Coupled with UiPath's agentic automation and orchestration platform, banks and

    2/6/26 7:30:00 AM ET
    $PATH
    Computer Software: Prepackaged Software
    Technology

    Verity and Bushel Announce Integration to Advance Traceable Agricultural Practices Across the Supply Chain

    ENGLEWOOD, Colo. and FARGO, N.D., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Verity Holdings, LLC, a wholly owned subsidiary of Gevo, Inc. (NASDAQ:GEVO), and Bushel today announced an integration that will connect Bushel's on-farm data with Verity's sustainability modeling and compliance platform. This integration supports the traceability and documentation of agricultural production practices that can influence carbon intensity outcomes and increase credit value under Section 45Z. It also helps position the agricultural supply chain for evolving carbon programs and market-based opportunities for traceable grain. The integration will give agribusinesses and producers a clearer path to participate

    2/4/26 5:10:14 PM ET
    $GEVO
    Major Chemicals
    Industrials

    $ACOR
    $AGLE
    $AHI
    $AI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Director Saunders Scott J

    4 - Nutex Health, Inc. (0001479681) (Issuer)

    2/9/26 1:04:42 PM ET
    $NUTX
    Real Estate

    SEC Form 4 filed by Director Reed Michael Lee

    4 - Nutex Health, Inc. (0001479681) (Issuer)

    2/9/26 1:01:09 PM ET
    $NUTX
    Real Estate

    SEC Form 4 filed by Director Grenas Cheryl Yvonne

    4 - Nutex Health, Inc. (0001479681) (Issuer)

    2/9/26 12:56:37 PM ET
    $NUTX
    Real Estate

    $ACOR
    $AGLE
    $AHI
    $AI
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    December 14, 2023 - FDA Warns Nine Manufacturers, Distributors of Unapproved Antimicrobials for Animals

    For Immediate Release: December 14, 2023 Today, the U.S. Food and Drug Administration is announcing the issuance of nine warning letters to manufacturers and distributors of unapproved and misbranded antimicrobial animal drugs for violations of federal law. The agency is concerned because these products contain antimicrobials that are important in human medicine and using them without medical oversight contribut

    12/14/23 9:00:20 AM ET
    $CHWY
    Catalog/Specialty Distribution
    Consumer Discretionary

    $ACOR
    $AGLE
    $AHI
    $AI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Huang Chiao Chieh bought $600,001 worth of shares (262,009 units at $2.29), increasing direct ownership by 23% to 1,421,219 units (SEC Form 4)

    4 - ENERGY FOCUS, INC/DE (0000924168) (Issuer)

    12/31/25 9:21:21 AM ET
    $EFOI
    Building Products
    Consumer Discretionary

    CEO and Chairman Rachman Ilya M bought $4,976 worth of shares (746 units at $6.67), increasing direct ownership by 0.07% to 1,141,683 units (SEC Form 4)

    4 - Immix Biopharma, Inc. (0001873835) (Issuer)

    12/10/25 6:49:30 PM ET
    $IMMX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    CFO Morris Gabriel S exercised 156,000 in-the-money shares at a strike of $0.80 and bought $5,067 worth of shares (770 units at $6.58), increasing direct ownership by 0.26% to 291,429 units (SEC Form 4)

    4 - Immix Biopharma, Inc. (0001873835) (Issuer)

    12/10/25 6:47:20 PM ET
    $IMMX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACOR
    $AGLE
    $AHI
    $AI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Mizuho initiated coverage on Immix Biopharma with a new price target

    Mizuho initiated coverage of Immix Biopharma with a rating of Outperform and set a new price target of $14.00

    2/9/26 7:01:42 AM ET
    $IMMX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    KE Holdings downgraded by Goldman with a new price target

    Goldman downgraded KE Holdings from Buy to Neutral and set a new price target of $19.00

    2/3/26 6:53:05 AM ET
    $BEKE
    Real Estate
    Finance

    Rosenblatt initiated coverage on Credo Technology Group with a new price target

    Rosenblatt initiated coverage of Credo Technology Group with a rating of Neutral and set a new price target of $170.00

    1/21/26 8:55:06 AM ET
    $CRDO
    Semiconductors
    Technology

    $ACOR
    $AGLE
    $AHI
    $AI
    SEC Filings

    View All

    SEC Form S-8 filed by Uranium Energy Corp.

    S-8 - URANIUM ENERGY CORP (0001334933) (Filer)

    2/6/26 4:30:58 PM ET
    $UEC
    Other Metals and Minerals
    Basic Materials

    Hewlett Packard Enterprise Company filed SEC Form 8-K: Leadership Update

    8-K - Hewlett Packard Enterprise Co (0001645590) (Filer)

    2/6/26 4:09:56 PM ET
    $HPE
    Retail: Computer Software & Peripheral Equipment
    Technology

    SEC Form SCHEDULE 13G filed by Rain Enhancement Technologies Holdco Inc.

    SCHEDULE 13G - Rain Enhancement Technologies Holdco, Inc. (0002028293) (Subject)

    2/6/26 2:30:22 PM ET
    $RAIN
    Industrial Machinery/Components
    Technology

    $ACOR
    $AGLE
    $AHI
    $AI
    Leadership Updates

    Live Leadership Updates

    View All

    Repare Shareholders Approve Acquisition by XenoTherapeutics, Inc.

    Repare Therapeutics Inc. ("Repare" or the "Company") (NASDAQ:RPTX), a clinical-stage precision oncology company, today announced that its Shareholders (as defined below) have approved the acquisition of all of the issued and outstanding common shares of the Company (the "Common Shares" and the holders of the Common Shares, the "Shareholders") by XenoTherapeutics, Inc. and Xeno Acquisition Corp. (jointly "Xeno") a non-profit biotechnology company, by way of a statutory plan of arrangement (the "Transaction" or the "Arrangement") at the special meeting of Shareholders held today (the "Meeting"). The special resolution approving the Arrangement was approved by: (i) 99.76% of the votes cast b

    1/16/26 4:58:00 PM ET
    $RPTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Gevo Strengthens Operational Leadership Amid Ongoing Growth and Succession Planning

    ENGLEWOOD, Colo., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ:GEVO), a leader in renewable fuels and chemicals, and carbon management, today announced the addition of agricultural industry veteran Greg Hanselman as executive vice president, operations and engineering. Mr. Hanselman's hire is part of Gevo's ongoing growth and succession planning, as Chris Ryan, Gevo's long-time chief operating officer, is planning to retire from the company in June of 2026. Mr. Hanselman comes to Gevo from previous roles in global agribusiness leadership as vice president of global engineering for Ingredion (NYSE:INGR), and as senior vice president of global manufacturing for Tate & Lyle, both lea

    1/5/26 9:00:00 AM ET
    $GEVO
    $INGR
    Major Chemicals
    Industrials
    Packaged Foods
    Consumer Staples

    JFrog Appoints Genefa Murphy as Chief Marketing Officer to Accelerate Its Next Growth Phase

    Company Extends Executive Leadership to Lead the AI-Driven Software Supply Chain Evolution JFrog Ltd. (NASDAQ:FROG), the Liquid Software company, today announced the appointment of Genefa Murphy as Chief Marketing Officer, effective immediately. Murphy brings an expansive resume to JFrog, as a seasoned CMO and go-to-market (GTM) leader with established success in driving global enterprise software growth and strategic business expansion. Coming from software development product management roots and public company GTM leadership, Ms. Murphy also holds a PhD in User Acceptance of New Technology, from the University of Wales and is a veteran of multiple boards of directors in technology and

    1/5/26 8:00:00 AM ET
    $FIVN
    $FROG
    $HPE
    EDP Services
    Technology
    Computer Software: Prepackaged Software
    Retail: Computer Software & Peripheral Equipment

    $ACOR
    $AGLE
    $AHI
    $AI
    Financials

    Live finance-specific insights

    View All

    UiPath Acquires WorkFusion, Strengthening Agentic Solutions for Financial Services

    UiPath (NYSE:PATH), a global leader in agentic automation, today announced the acquisition of WorkFusion, a pioneer in AI agents for financial crime compliance. The acquisition expands and strengthens the UiPath portfolio of agentic AI-powered industry solutions for the financial services and banking industries, including processes and workflows for financial crimes compliance such as anti-money laundering (AML) and know your customer (KYC) operations. WorkFusion's pre-built library of AI agents automates the most labor-intensive aspects of financial crime compliance, from customer screening to investigations. Coupled with UiPath's agentic automation and orchestration platform, banks and

    2/6/26 7:30:00 AM ET
    $PATH
    Computer Software: Prepackaged Software
    Technology

    Pure Storage Announces Date and Conference Call Information for Fiscal Fourth Quarter and Full Year 2026 Financial Results

    SANTA CLARA, Calif., Feb. 4, 2026 /PRNewswire/ -- Pure Storage® (NYSE:PSTG), the IT pioneer that delivers the world's most advanced data storage technology and services, today announced it will host a conference call on Wednesday, February 25, at 2:00 p.m. PT to discuss its financial results for fiscal fourth quarter and full year 2026 ended February 1, 2026. This conference call will be held following the release of Pure Storage's financial results. Fiscal Q4 and Full Year 2026 Conference Call Details A live audio broadcast of the conference call will be available at the Pure

    2/4/26 4:05:00 PM ET
    $PSTG
    Electronic Components
    Technology

    MongoDB, Inc. Announces Date of Fourth Quarter and Full Fiscal 2026 Earnings Call

    NEW YORK, Feb. 4, 2026 /PRNewswire/ -- MongoDB, Inc. (NASDAQ:MDB) will report its fourth quarter and full fiscal year 2026 financial results for the three months ended January 31, 2026, after the U.S. financial markets close on Monday, March 2, 2026. In conjunction with this announcement, MongoDB will host a conference call on Monday, March 2, 2026, at 5:00 p.m. (Eastern Time) to discuss the Company's financial results and business outlook. A live webcast of the call will be available on the "Investor Relations" page of the Company's website at http://investors.mongodb.com. To

    2/4/26 4:05:00 PM ET
    $MDB
    Computer Software: Prepackaged Software
    Technology

    $ACOR
    $AGLE
    $AHI
    $AI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by MongoDB Inc.

    SC 13G/A - MongoDB, Inc. (0001441816) (Subject)

    11/15/24 10:35:42 AM ET
    $MDB
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13G/A filed by Repare Therapeutics Inc.

    SC 13G/A - Repare Therapeutics Inc. (0001808158) (Subject)

    11/14/24 9:00:57 PM ET
    $RPTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Centessa Pharmaceuticals plc

    SC 13G/A - Centessa Pharmaceuticals plc (0001847903) (Subject)

    11/14/24 5:43:48 PM ET
    $CNTA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACOR
    $AGLE
    $AHI
    $AI
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Insider Analysis: Purchase at Immix Biopharma Inc. on Jun 5

    Recent insider purchases at Immix Biopharma Inc. have caught the attention of investors, with Morris Gabriel S leading the way by acquiring $5,973 worth of shares on June 5, 2024. This transaction involved 3,300 units at a price of $1.81 per share, increasing Gabriel's direct ownership by 1% to 283,334 units, as reported in SEC Form 4. This move indicates Gabriel's confidence in the company's potential and may be seen as a positive signal by market participants. Click here for more details. Looking back at previous insider transactions, we can identify a few interesting patterns. On May 15, 2024, Rachman Ilya M purchased $9,660 worth of shares, comprising 4,300 units at $2.25 per share, whi

    6/10/24 1:09:24 AM ET
    $IMMX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Stock Movement: Insider Purchase at electroCore Inc. on Jun 6

    **Analysis of Recent Insider Purchase at electroCore Inc.** An insider purchase was recently made at electroCore Inc. by Goldberger Daniel S on June 6, 2024. This transaction involved the purchase of $247,587 worth of shares, equating to 38,505 units at an average price of $6.43 per share. As a result of this purchase, Goldberger's direct ownership in the company increased by 18% to 249,565 units, as reported in the SEC Form 4 filing. Looking at the historical insider transactions at electroCore Inc., several interesting patterns emerge when analyzing the timing, price, volume, purchaser's role, and more. On August 8, 2023, Goldstein Julie Ann and Cuneo F Peter both filed SEC Form 4 report

    6/10/24 12:57:57 AM ET
    $ECOR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care